Navigation Links
Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
Date:1/19/2010

ny of our core products; our exposure to product liability claims and product recalls and the possibility that we may not be able to adequately insure ourselves; our ability to protect our proprietary technology; our ability to successfully implement our in-licensing and acquisition strategy; the availability of third-party reimbursement for our products; the outcome of any pending or future litigation or claims by the government; our dependence on sales to a limited number of large pharmacy chains and wholesale drug distributors for a large portion of our total net sales; a determination by a regulatory agency that we are engaging in inappropriate sales or marketing activities, including promoting the "off-label" use of our products; the loss of branded product exclusivity periods and related intellectual property; and exposure to securities that are subject to market risk including auction-rate securities the market for which is currently illiquid; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission on March 2, 2009.  The forward-looking statements in this press release are qualified by these risk factors.  These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results.  We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

SOURCE Endo Pharmaceuticals

RELATED LINKS
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , September 4, 2015 ... by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by ... and by Product - Global Forecast to 2020", published ... reach USD 2.5 Billion by 2020, growing at a ... to 2020. Browse 139 Tables and ...
(Date:9/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... & Renshaw 17 th Annual Global Investment Conference, ... York City .  Dr. Michael Berelowitz , ... September 9, 2015. Presentation Details: ...
(Date:9/4/2015)... N.J. , Sept. 4, 2015  IGI Laboratories, ... based specialty generic pharmaceutical company, today announced ... (ANDA) to the U.S. Food and Drug Administration (FDA) ... ANDA submissions now pending at the FDA to twenty-nine. ... of the Company, commented, "We believe our current pipeline ...
Breaking Medicine Technology:Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2
... A Denver ophthalmologist recently became the first in Colorado ... raising the bar for patient care in the state while ... Paul Cutarelli, director of Cutarelli Vision in Denver and Fort ... in the eye of a 70-year-old man whose cataracts in ...
... (NYSE: IMA ), a global leader in enabling individuals to ... rapid diagnostics and health management, today announced its financial results for ... for the third quarter of 2009: , Net ... to $438.8 million for the third quarter of 2008. GAAP ...
Cached Medicine Technology:Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 2Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 3Inverness Medical Innovations Announces Third Quarter 2009 Results 2Inverness Medical Innovations Announces Third Quarter 2009 Results 3Inverness Medical Innovations Announces Third Quarter 2009 Results 4Inverness Medical Innovations Announces Third Quarter 2009 Results 5Inverness Medical Innovations Announces Third Quarter 2009 Results 6Inverness Medical Innovations Announces Third Quarter 2009 Results 7Inverness Medical Innovations Announces Third Quarter 2009 Results 8Inverness Medical Innovations Announces Third Quarter 2009 Results 9Inverness Medical Innovations Announces Third Quarter 2009 Results 10Inverness Medical Innovations Announces Third Quarter 2009 Results 11Inverness Medical Innovations Announces Third Quarter 2009 Results 12Inverness Medical Innovations Announces Third Quarter 2009 Results 13Inverness Medical Innovations Announces Third Quarter 2009 Results 14Inverness Medical Innovations Announces Third Quarter 2009 Results 15Inverness Medical Innovations Announces Third Quarter 2009 Results 16Inverness Medical Innovations Announces Third Quarter 2009 Results 17
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a variety of ... which affects hospitals’ abilities to provide quality service to those with serious needs, increases ... problem has recently presented itself, the new telemedicine platform and app, DocChat . ...
(Date:9/4/2015)... ... , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and ... 400 meters final, with an impressive 44.89 seconds at the 2015 North American, Central ... in August 2015. The 44.64 time is a new NACAC Championship record. , ...
(Date:9/4/2015)... Washington, DC (PRWEB) , ... September 04, 2015 ... ... dollar-wise they all pale in comparison to settlements under the Stark physician self-referral ... an upcoming Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... a Labor Day offer that cannot be passed up. FiltersFast.com, will ship ... necessary air and water filtration product replacements. Take advantage of this promotion now ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Friday night, Chicago ... hosting Generation Rescue’s A Night of Hope event supporting families affected by autism, raising ... Rowena and Joe Salas, joined together at the Oscar Swan Inn to support the ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... , , , ... were considered prized possessions of the Emperors of China and were personally ... Monarchs of Europe and discerning people all over the world. This luxurious ... most popular dog breeds today. , , ...
... , KUALA LUMPUR, Malaysia, Aug. 26 ... privatization within the healthcare service provision and upgrading of existing ... services has also received positive impetus from growing promotion of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , According ...
... Health Group Inc. ("AIM" or the "Company") (TSXV - AHG), ... net income for the three month period ended June 30, ... $118,223 in the same period in 2008. At the same ... quarter-over-quarter basis. The Company also announced that revenues increased 102% ...
... is the GlaxoSmithKline statement in response to the FDA,s Early Communication about ... stands firmly behind the safety and efficacy of alli . ... that there is no evidence that alli causes liver damage. ... cases on liver injury associated with the use of orlistat/alli. Any routine ...
... restart production of missing protein , TUESDAY, Aug. 25 ... appears to jump-start the production of a crucial protein ... researchers report. , The treatment so far is only ... debilitating and ultimately fatal disease, but scientists are hopeful ...
... with coronary artery disease-induced congestive heart failure or heart ... radiation therapy for treatment of prostate cancer have an ... in the August 26 issue of JAMA . ... options available for treatment, including the use of brachytherapy ...
Cached Medicine News:Health News:Royal Canin Continues to Pioneer the Pet Food Industry With an Exclusive Diet Just for Pugs 2Health News:Frost & Sullivan: Growing Healthcare Tourism in Malaysia 2Health News:Frost & Sullivan: Growing Healthcare Tourism in Malaysia 3Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 2Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 3Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 4Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 5Health News:Experimental Treatment Could Fight Muscular Dystrophy 2Health News:Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: